Tharimmune, Inc. | WebDisclosure

Basculer en Français

10449	Companies
219336	Keywords
148791	Articles
116018	Press releases

Home
Companies
Tharimmune, Inc.

PRESS RELEASE

published on 05/19/2025 at 14:01, 1 year ago

Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
Tharimmune, Inc. appoints James Gordon Liddy as strategic advisor for TH104 development, targeting high-potency opioid exposure. FDA feedback positive for prophylaxis indication

Tharimmune Inc. FDA Feedback High-Potency Opioids James Gordon Liddy TH104 Development
BRIEF

published on 05/06/2025 at 14:06, 1 year ago

Tharimmune Reports Positive Phase 1 Results for TH104

Tharimmune Inc. FDA Feedback Phase 1 Study Opioid Prophylaxis TH104 Buccal Film
BRIEF

published on 05/06/2025 at 14:06, 1 year ago

Tharimmune annonce des résultats positifs de phase 1 pour le TH104

Tharimmune Inc. Étude De Phase 1 Commentaires De La FDA Prophylaxie Aux Opioïdes Film Buccal TH104
PRESS RELEASE

published on 05/06/2025 at 14:01, 1 year ago

Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback
Tharimmune, Inc. presents promising pharmacokinetic and metabolism data of TH104, a buccal film of nalmefene, for prophylaxis against opioid exposure. Study results showcased at Digestive Disease Week 2025

Tharimmune Inc. TH104 Buccal Film Pharmacokinetic Study Opioid Prophylaxis
BRIEF

published on 05/01/2025 at 14:06, 1 year ago

Le TH104 de Tharimmune sera présenté lors de conférences médicales importantes

Biopharmaceutique TH104 Tharimmune DDW 2025 EASL 2025
BRIEF

published on 05/01/2025 at 14:06, 1 year ago

Tharimmune's TH104 to Be Presented at Notable Medical Conferences

TH104 Biopharmaceutical Tharimmune DDW 2025 EASL 2025
PRESS RELEASE

published on 05/01/2025 at 14:01, 1 year ago

Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences
Tharimmune, Inc. announces presentation of clinical data on lead drug TH104 at DDW and EASL Annual Meetings in May 2025, addressing unmet medical needs in immunology & inflammation

Tharimmune Inc. TH104 Clinical Data Immunology Unmet Medical Needs
BRIEF

published on 04/30/2025 at 14:06, 1 year ago

Tharimmune élargit son conseil d'administration avec de nouvelles nominations

Stratégie De Croissance Biopharmaceutique Direction Nominations Au Conseil D'administration Tharimmune
BRIEF

published on 04/30/2025 at 14:06, 1 year ago

Tharimmune Expands Board with New Appointments

Growth Strategy Biopharmaceutical Leadership Board Appointments Tharimmune
PRESS RELEASE

published on 04/30/2025 at 14:01, 1 year ago

Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors
Tharimmune, Inc. appoints Clay Kahler and Gary Stetz to its Board of Directors, expanding to 9 members. Kahler brings life sciences expertise while Stetz contributes financial acumen

Board Of Directors Financial Expertise Tharimmune Clay Kahler Gary Stetz

Accesswire

Published on 05/25/2026 at 13:30, 13 hours 26 minutes ago

ZTEST Electronics Inc. Announces Fiscal 2026 Q3 Results with 13.9% Year Over Year Revenue Growth
Published on 05/25/2026 at 13:30, 13 hours 26 minutes ago

ESgold Corp. Engages ICP Securities for Automated Market Making Services
Published on 05/23/2026 at 19:45, 2 days 7 hours ago

Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 2 days 23 hours ago

UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 2 days 23 hours ago

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges

View all ACCESSWIRE

EQS Group

Published on 05/25/2026 at 19:00, 7 hours 56 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 18 MAI 2026 au 22 MAI 2026
Published on 05/25/2026 at 18:45, 8 hours 10 minutes ago

À bord du Tianzhou-10 se trouve une « fabrication de Binzhou » – la force d'innovation scientifique et technologique de Binzhou s'élance avec puissance vers l'espace
Published on 05/25/2026 at 18:45, 8 hours 10 minutes ago

'Made in Binzhou' Heads to Tianzhou-10 Cargo Spacecraft——Binzhou Sci-Tech Power Embarks on a Hardcore Space Mission
Published on 05/25/2026 at 18:00, 8 hours 55 minutes ago

Huawei Hosts 3rd Global C&I Visionaries Summit, Shaping a Greener Future Across Diverse Industries
Published on 05/25/2026 at 17:00, 9 hours 55 minutes ago

TCMA x Chulalongkorn University Join Forces with Canadian Partners to Advance Strategic Collaboration for a Low-Carbon Industry toward Net Zero 2050

Les Echos

Published on 05/25/2026 at 18:00, 8 hours 56 minutes ago

Déclaration des transactions sur actions propres réalisées du 18/05/2026 au 24/05/2026
Published on 05/25/2026 at 17:45, 9 hours 11 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 05/25/2026 at 17:45, 9 hours 11 minutes ago

Weekly share buyback
Published on 05/22/2026 at 19:35, 3 days 7 hours ago

PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 3 days 8 hours ago

Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026

View all LES ECHOS COMFI WIRE